• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工作场所环境中接种疫苗前 RT-PCR 阴性接触者具有较高的 SARS-CoV-2 中和抗体水平。

Pre-vaccination RT-PCR negative contacts in workplace settings show high, SARS COV-2 neutralizing antibody levels.

机构信息

Department of Microbiology, Faculty of Medicine, University of Peradeniya, Peradeniya, 20400, Sri Lanka.

Office of the Regional Director of Health Services, Kandy, Sri Lanka.

出版信息

BMC Public Health. 2022 Oct 25;22(1):1961. doi: 10.1186/s12889-022-14381-5.

DOI:10.1186/s12889-022-14381-5
PMID:36284261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9593990/
Abstract

BACKGROUND

Asymptomatic SARS-CoV-2 infection occurring in RT-PCR negative individuals represent a poorly characterized cohort with important infection control connotations. While household and community-based studies have evaluated seroprevalence of antibody and transmission dynamics in this group, workplace-based data is currently unavailable.

METHODS

A cohort study was carried out in July 2021, during and immediately following the peak of the 3 wave of COVID-19 in Sri Lanka, prior to mass vaccination. A total of 92 unvaccinated individuals between the ages of 17-65 years were purposively sampled from an office and two factory settings. The selected cohort that had been exposed to RT-PCR positive cases in the workplace was tested RT-PCR negative. Serological samples collected six weeks post exposure were tested for anti-SARS-CoV-2 neutralizing antibody.

RESULTS

The seroprevalence for SARS-CoV-2 specific neutralizing antibodies in the overall cohort was 63.04% (58/92). Seroprevalences in the office setting, factory setting 1 and factory setting 2 were 69.2% (9/13), 55.7% (34/61) and 83.33% (15/18), respectively. Primary risk factor associated with seropositivity was face to face contact with no mask for > 15 min (p < 0.024, Odds Ratio (OR); 5.58, 95%CI;1.292- 25.65). Individuals with workspace exposure had significantly higher levels of neutralizing antibodies than those who did not (percentage neutralization in assay 63.3% (SD:21)vs 45.7% (SD:20), p = 0.0042), as did individuals who engaged socially without protective measures (62.4 (SD:21.6)% vs 49.7 (SD:21)%, p = 0.026).

CONCLUSION

There was a high seroprevalence for SARS-CoV-2 specific neutralizing antibodies among RT-PCR negative contacts in workplace settings in Sri Lanka. Higher levels of transmission of SARS-CoV-2 infection than estimated based on RT-PCR positive contact data indicate need for targeted infection control measures in these settings during future outbreaks.

摘要

背景

在 RT-PCR 检测结果为阴性的个体中出现无症状的 SARS-CoV-2 感染,这代表了一个特征描述较差的群体,具有重要的感染控制含义。虽然家庭和社区研究已经评估了该群体中的抗体血清阳性率和传播动态,但目前尚无基于工作场所的数据。

方法

在 2021 年 7 月,斯里兰卡 COVID-19 第三波疫情高峰期间和之后立即进行了一项队列研究,当时尚未大规模接种疫苗。从一个办公室和两个工厂中,有目的地选择了年龄在 17-65 岁之间的 92 名未接种疫苗的个体。在工作场所接触过 RT-PCR 阳性病例的选定队列中,检测结果均为 RT-PCR 阴性。在接触后 6 周采集血清样本,检测针对 SARS-CoV-2 的中和抗体。

结果

总体队列中 SARS-CoV-2 特异性中和抗体的血清阳性率为 63.04%(58/92)。在办公室、工厂 1 和工厂 2 中,血清阳性率分别为 69.2%(9/13)、55.7%(34/61)和 83.33%(15/18)。与血清阳性相关的主要危险因素是面对面接触且未戴口罩超过 15 分钟(p<0.024,优势比(OR);5.58,95%置信区间;1.292-25.65)。与未暴露于工作场所的个体相比,暴露于工作场所的个体具有更高水平的中和抗体(在检测中中和抗体的百分比分别为 63.3%(SD:21)和 45.7%(SD:20),p=0.0042),并且与未采取保护措施进行社交的个体相比,其水平更高(62.4%(SD:21.6)%和 49.7%(SD:21)%,p=0.026)。

结论

在斯里兰卡工作场所的 RT-PCR 检测结果为阴性的接触者中,SARS-CoV-2 特异性中和抗体的血清阳性率较高。SARS-CoV-2 感染的传播水平高于基于 RT-PCR 阳性接触者数据的估计,这表明在未来的疫情中,需要在这些环境中采取有针对性的感染控制措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/87641404c021/12889_2022_14381_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/abb092e60b4e/12889_2022_14381_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/1d05000d1835/12889_2022_14381_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/15482e12d37e/12889_2022_14381_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/150bf990ba86/12889_2022_14381_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/5362a78ab7bb/12889_2022_14381_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/87641404c021/12889_2022_14381_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/abb092e60b4e/12889_2022_14381_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/1d05000d1835/12889_2022_14381_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/15482e12d37e/12889_2022_14381_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/150bf990ba86/12889_2022_14381_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/5362a78ab7bb/12889_2022_14381_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/9594959/87641404c021/12889_2022_14381_Fig6_HTML.jpg

相似文献

1
Pre-vaccination RT-PCR negative contacts in workplace settings show high, SARS COV-2 neutralizing antibody levels.工作场所环境中接种疫苗前 RT-PCR 阴性接触者具有较高的 SARS-CoV-2 中和抗体水平。
BMC Public Health. 2022 Oct 25;22(1):1961. doi: 10.1186/s12889-022-14381-5.
2
Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.在 SARS-CoV-2 爆发期间和之后,两家长期护理机构工作人员的持久抗体反应。
Microbiol Spectr. 2021 Sep 3;9(1):e0022421. doi: 10.1128/Spectrum.00224-21. Epub 2021 Jul 21.
3
Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort.埃及 2019 年冠状病毒病的发病率、家庭传播和中和抗体血清阳性率:基于社区的队列研究结果。
PLoS Pathog. 2021 Mar 11;17(3):e1009413. doi: 10.1371/journal.ppat.1009413. eCollection 2021 Mar.
4
Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study.利用血清学数据洞察 SARS-CoV-2 的 RT-PCR 检测实际性能:一项队列研究。
Lancet Microbe. 2021 Feb;2(2):e79-e87. doi: 10.1016/S2666-5247(20)30200-7. Epub 2021 Jan 19.
5
Characteristics of Immunogenicity against SARS-CoV-2 in a Community-Based Model of Care during the Fourth Wave of COVID-19 Outbreak in Ho Chi Minh City.胡志明市第四波 COVID-19 爆发期间基于社区护理模型中对 SARS-CoV-2 免疫原性的特征。
Yonsei Med J. 2024 Sep;65(9):501-510. doi: 10.3349/ymj.2023.0567.
6
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.加拿大蒙特利尔地区学校和日托中心儿童中 SARS-CoV-2 抗体的血清阳性率。
JAMA Netw Open. 2021 Nov 1;4(11):e2135975. doi: 10.1001/jamanetworkopen.2021.35975.
7
SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.SARS-CoV-2 特异性中和抗体反应在 COVID-19 大流行第一波后挪威医护人员中的前瞻性队列研究。
J Infect Dis. 2021 Feb 24;223(4):589-599. doi: 10.1093/infdis/jiaa737.
8
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.印度克什米尔地区不同工作场所暴露风险的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):274-281. doi: 10.12788/jhm.3609.
9
Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study.从儿童 SARS-CoV-2 抗体低血清阳性率中吸取的教训:一项横断面研究。
Pediatr Allergy Immunol. 2021 May;32(4):762-770. doi: 10.1111/pai.13459. Epub 2021 Feb 15.
10
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.

本文引用的文献

1
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka.斯里兰卡科伦坡市地区 SARS-CoV-2 感染的血清阳性率。
Front Public Health. 2021 Nov 12;9:724398. doi: 10.3389/fpubh.2021.724398. eCollection 2021.
2
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.南非豪登省估计的 SARS-CoV-2 感染率和病死率:一项基于人群的血清流行病学调查。
Int J Epidemiol. 2022 May 9;51(2):404-417. doi: 10.1093/ije/dyab217.
3
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
无症状 SARS-CoV-2 感染的免疫学:关键问题是什么?
Nat Rev Immunol. 2021 Dec;21(12):762-768. doi: 10.1038/s41577-021-00631-x. Epub 2021 Oct 19.
4
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.无症状 SARS-CoV-2 感染:系统评价和荟萃分析。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2109229118.
5
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.健康工作者单次接种 AZD1222/Covishield 疫苗的免疫应答。
Nat Commun. 2021 Jul 29;12(1):4617. doi: 10.1038/s41467-021-24579-7.
6
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体的全球血清流行率:一项系统综述和荟萃分析。
PLoS One. 2021 Jun 23;16(6):e0252617. doi: 10.1371/journal.pone.0252617. eCollection 2021.
7
Review of the risk factors for SARS-CoV-2 transmission.严重急性呼吸综合征冠状病毒2传播的风险因素综述。
World J Clin Cases. 2021 Mar 6;9(7):1499-1512. doi: 10.12998/wjcc.v9.i7.1499.
8
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population.SARS-CoV-2 抗体检测在人群中估算 COVID-19 患病率。
Cell Rep Med. 2021 Feb 16;2(2):100191. doi: 10.1016/j.xcrm.2021.100191. Epub 2021 Jan 14.
9
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.急性 COVID-19 疾病不同严重程度患者中的 SARS-CoV-2 中和抗体。
Sci Rep. 2021 Jan 21;11(1):2062. doi: 10.1038/s41598-021-81629-2.
10
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020.2020 年 12 月:公共卫生策略应对 SARS-CoV-2 社区高传播水平和相关死亡的指导摘要。
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1860-1867. doi: 10.15585/mmwr.mm6949e2.